期刊文献+

口蹄疫病毒3C蛋白酶切割宿主蛋白PCBP2 被引量:3

Foot-and-mouth disease virus 3C protease cleaves RNA-binding protein of poly(C) binding protein 2
在线阅读 下载PDF
导出
摘要 口蹄疫病毒(FMDV)3C蛋白酶(3Cpro)能够通过切割翻译起始因子4G(eIF4G)抑制宿主蛋白合成,而宿主多聚胞嘧啶结合蛋白2(PCBP2)的主要功能之一是参与蛋白质合成。本研究通过western blot检测显示,在FMDV感染BHK-21细胞中PCBP2蛋白水平显著降低。为鉴定FMDV 3Cpro是否具有切割PCBP2蛋白的功能,本研究采用免疫共沉淀试验和激光共聚焦检测显示,FMDV 3Cpro和PCBP2在细胞内存在相互作用,并且共定位于细胞质中。进一步研究显示,FMDV 3Cpro能够切割PCBP2,而且具有剂量依赖性。此外,FMDV 3Cpro活性位点突变(H46Y)试验结果表明,FMDV 3Cpro的蛋白酶活性是切割蛋白PCBP2所必需的。FMDV 3Cpro切割PCBP2靶位点序列的鉴定及FMDV 3Cpro切割PCBP2的生物学意义有待深入研究。 Host protein synthesis is inhibited in foot-and-mouth disease virus (FMDV) infected host cells by cleaving the translation initiation factor 4G (elF4G) via FMDV 3C proteinase (3Cpro). Then the RNA-binding protein of poly (C) binding protein 2 (PCBP2) was also involved in protein synthesis. In this study, it was found that the protein level of PCBP2 was significantly reduction in FMDV infected BHK-21 cells. To identify whether PCBP2 was cleaved by FMDV 3Cpro to inhibit the host protein synthesis, the co-immunoprecipitation and confocal laser scan microscopy assay results demonstrated that FMDV 3Cpro interacted and colocalized with host protein PCBP2. In addition, PCBP2 was cleaved by FMDV 3Cpro in a dose-dependent manner. Further test showed that the H46 was the crucial amino acid for FMDV 3Cpro activity required for cleavage of PCBP2, which was proved by H46y point mutation in the activity domain of FMDV 3Cpro. However, the target cleavage sites in PCBP2 need to be further identified.
出处 《中国预防兽医学报》 CAS CSCD 北大核心 2014年第6期419-422,共4页 Chinese Journal of Preventive Veterinary Medicine
基金 国家自然科学基金(31300139) 中国农业科学院基本科研业务费预算增量项目(2013ZL034)
关键词 口蹄疫病毒 3C蛋白酶 PCBP2 切割 foot-and-mouth disease virus 3C proteinase PCBP2 cleavage
  • 相关文献

参考文献12

  • 1Mason P W, Grubman M J, Baxt B.Molecular basis of pathogenesis of FMDV [J].Virus Res, 2003, 91(1): 9-32.
  • 2Wang Dang, Fang Liu-rong, Li Ping, et al.The leader proteinase of foot-and-mouth disease virus negatively regulates the type I interferon pathway by acting as a viral deubiquitinase [J].J Virol, 2011, 85(8): 3758-3766.
  • 3Wang Dang, Fang Liu-rong, Li Kui, et al.Foot-and-mouth disease virus 3C protease cleaves NEMO to impair innate immune signaling [J].J Virol, 2012, 86(17): 9311-9322.
  • 4Makeyev A V, Liebhaber S A.The poly(C)-binding proteins: a multiplicity of functions and a search for mechanisms [J].RNA, 2002, 8(3): 265-278.
  • 5Bedard K M, Walter B L, Semler B L.Multimerization of poly(C) binding protein 2 is required for translation initiation mediated by viral IRES [J].RNA, 2004, 10: 1266-1276.
  • 6Barral P M, Sarkar D, Fisher P B,et al.RIG-I is cleaved during picornavirus infection [J].Virology, 2009, 391(2): 171-176.
  • 7Wang Hai-wei, Zhao Lei, Wan Li, et al.Identification of a conformational epitope on the VP1 G-H Loop of type Asia1 foot- and-mouth disease virus defined by a protective monoclonal antibody [J].Vet Microbiol, 2011, 148: 189-199.
  • 8Yu Yong-zhong, Wang Hai-wei, Zhao Lei, et al.Fine mapping of a foot-and-mouth disease virus epitope recognized by serotype-independent monoclonal antibody 4B2 [J].J Microbiol, 2011, 49(1): 94-101.
  • 9Barral P M, Morrison J M, Drahos J,et al.MDA-5 is cleaved in poliovirus-infected cells [J].J Virol, 2007, 81(8): 3677-3684.
  • 10Strong R.Sequential modification of translation initiation factor eIF4GI by two different foot-and-mouth disease virus proteases within infected baby hamster kidney cells: identification of the 3Cpro cleavage site [J].J Gen Virol, 2004, 85(10): 2953-2962.

同被引文献31

  • 1田纯见,毕英佐,曹永长,谢青梅.口蹄疫病毒3C蛋白酶的T4噬菌体表面展示[J].中国兽医科学,2006,36(7):519-522. 被引量:2
  • 2杨彬,柳纪省.口蹄疫病毒3C蛋白酶的结构及功能研究进展[J].动物医学进展,2007,28(9):87-90. 被引量:7
  • 3Sobrino F, Saiz M, Jimenez-Clavero M A, et al. Foot-and- mouth disease virus: a long known virus, but a current threat [ J].Vet Res,2001,32( 1 ) : 1-30.
  • 4Marvin J Grubman, Barry Baxt. Foot-and-mouth disease [ J ]. Clinical Microbiology Reviews, 2004,17:465-493.
  • 5Sfiz M, Jim6Nez-Clavero M A. Foot-and-mouth disease virus: biology and prospects for disease control [ J ]. Microbes and In- fection, 2002,4 : 1183-1192.
  • 6Barnett P, Garland A J, Kitehing R P, et al. Aspects of emer- gency vaccination against ftrat-and-mouth disease[ J] .Comp lm- munol Microbiol Infect Dis, 2002,25 ( 5/6 ) : 345-364.
  • 7Pumpens P, Grens E. HBV core particles as a carrier for B cell/T cell epitopes [ J ]. Intervirology, 2001, 44 ( 2/3 ) : 98- 114.
  • 8Zhang J, Liu C B, Li R C, et al. Randomized-controlled phase II clinical trial of a bacterially expressed recombinant hepatitis E vaccine[J]. Vaccine, 2009, 27( 12): 1869-1874.
  • 9Nardin E H, Oliveira G A, Calvo-calle J M, et al. Phase I testing of a malaria vaccine composed of hepatitis B virus core particles expressing Plasmodium falciparum circumsporozoite epitopes[ J]. hffect Immun, 2004, 72(11 ): 6519-6527.
  • 10Zhu F C,Zhang J, Zhang X F, et al. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large- scale, randomised, double-blind placebo-controlled, phase 3 trial[J1. Lancet, 2010, 376(9744): 895-902.

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部